Leaders from Fortune 500 companies, tech start-ups, and universities joined Governor JB Pritzker Monday to announce a plan to make Chicago the nation’s “quantum technology capital” at M-Hub, a business incubator on Chicago’s Near West Side.

Yobee presented at the Health & Wellness Women in TechRise Chicago Competition, highlighting pioneering women founders, on April 12th.

Autism treatment has been a frequent target of private-equity disruption, but it's less common to see a health system's venture arm wade into the space.

Yobee was one of 16 Chicagoland CEOs giving 1-minute elevator pitches on April 2, 2024, at the Start-up Showcase & Board Member Match-up event at the Women in Bio (WIB) - 3.8 Initiative at Portal Innovations, LLC.

Ikaika was one of 16 Chicagoland CEOs giving 1-minute elevator pitches on April 2, 2024, at the Start-up Showcase & Board Member Match-up event at the Women in Bio (WIB) - 3.8 Initiative at Portal Innovations, LLC.

The Phoenix Center, a school for kids with disabilities, is using virtual reality to try to ease the journey of airport travel by leveraging Floreo's VR technology and the Meta Quest 2 headset.

Cambridge Cognition, which acquired Winterlight Labs in 2023, establishes a Scientific Advisory Board comprising experts in cognitive science and clinical trials to guide the integration of emerging trends like blood-based biomarkers and collaborative assessments.

Vivoryon Therapeutics N.V. is conducting an in-depth analysis of their Phase 2b results, including analyses of additional pre-specified exploratory endpoints (e.g. Winterlight Labs speech assessment) and distinct patient cohorts as defined in the statistical analysis plan.

New research shows talking speed might be a more telling indicator of cognitive decline and dementia than the occasional struggle to find words, with methods including analyzing speech patterns with AI-based software developed in collaboration with Winterlight Labs.

Yobee was featured in the Northwestern Journal talking about Yobee, a scalp-relief startup safe and effective for kids and adults.

The Chicago Biomedical Consortium showcased promising new biotech innovations at the Chicago BioCapital Summit that took place at Portal Innovations on November 2, 2023, including Ikaika's own CSO Dr. Alexis Demonbreun speaking about Ikaika's anti-fibrotic biologic technology.

Yobee published their second clinical trial with our ScalpMask in pediatrics in Clinical, Cosmetic and Investigational Dermatology, demonstrating that Yobee is safe and effective for kids and adults

The NIH National Institute on Aging awarded Grove Biopharma, Inc non-dilutive funding for their Nrf2 biologics treating neurodegenerative diseases.

Geneius Biotechnology, Inc., an immuno-oncology company developing a best-in-class personalized RNA-enabled T cell therapy platform for solid and liquid cancers, announced they will present at the upcoming 2023 American Association for Cancer Research (AACR) Annual Meeting.

Over the years, we have had many different types of requested Floreo experiences and a lot of them have made it into the app already!